Emerging agents and regimens for multiple myeloma

The outcomes of multiple myeloma (MM) have been improved significantly with the therapies incorporating proteasome inhibitors (PI), immunomodulatory drugs, monoclonal antibodies (MoAb) and stem cell transplant...

Source: Journal of Hematology and Oncology - November 9, 2020 Category: Hematology Authors: Yang Yang, Yi Li, Huiyao Gu, Mengmeng Dong and Zhen Cai Tags: Review Source Type: research